The Future of T1D: Unannounced Meal Management Technology
Many people living with type 1 diabetes (T1D) use automated insulin delivery (AID) systems to help manage blood glucose levels….
The Color of Your Skin Should Not Affect Your Diabetes Care
The color of a person’s skin should not affect their diabetes care, but it still does. Despite so many advancements…
DiabetesMine Innovation Summit Unveils New Tech & Products for Type 1 Diabetes
There is one common goal in the diabetes healthcare industry: we want to make life with type 1 diabetes (T1D)…
Emboldened to Innovate: Supporting All People Living with Diabetes
Regardless of your role, title, or experience, if you work in diabetes care, I venture that you share in the…
Making Diabetes Electronic Medical Record Data Actionable: Promoting Benchmarking and Population Health Improvement Using the T1D Exchange Quality Improvement Portal
Mungmode, A, Noor, N, Weinstock, R, Izquierdo, R, Indyk, J, DeSalvo, D, Corathers, S, Demeterco-Berggren, C, Hsieh, S, Jacobsen, L,…
Life with the DIY Loop
I’ve lived with type 1 diabetes for the past 20 years, and in that time frame, managing my diabetes has…
Pharma and Medtech CEOs at JPMorgan 2020 Weigh in on Insulin Pricing, Supply Issues, and Innovation
Executives of the Big Three pharma companies involved in diabetes research, development, and manufacturing — Eli Lilly and Co., Novo Nordisk, and Sanofi — spoke publicly this week at JPMorgan’s 2020 Healthcare conference on issues related to insulin pricing and supply.
